Shorla Pharma Announces Chief Commercial Officer

Shorla Pharma are delighted to announce the appointment of Chief Commercial Officer Nicholas Holsman, a highly experienced U.S. industry executive with in-depth experience in scaling oncology & specialty pharma enterprises. Nicholas Holsman will lead commercialization of novel oncology products.

Holsman has almost twenty years’ experience in leading commercial functions, with a focus on high growth start-up biotech companies. Most recently, he was Head of Commercial Operations at Oncopeptides, INC, where he was responsible for building the infrastructure to support the launch of PEPAXTO, a peptide-conjugated alkylator for the treatment of relapsed and refractory multiple myeloma patients.

Read more at:

https://www.businesswire.com/news/home/20210302005322/en/Shorla-Pharma-Announces-U.S.-Industry-Veteran-Nicholas-Holsman-as-Chief-Commercial-Officer

LATEST NEWS